Cargando…
Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy
BACKGROUND: Corticosteroids are routinely utilized to alleviate edema in patients with intracranial lesions and are first-line agents to combat immune-related adverse events (irAEs) that arise with immune checkpoint blockade treatment. However, it is not known if or when corticosteroids can be admin...
Autores principales: | Giles, Amber J., Hutchinson, Marsha-Kay N. D., Sonnemann, Heather M., Jung, Jinkyu, Fecci, Peter E., Ratnam, Nivedita M., Zhang, Wei, Song, Hua, Bailey, Rolanda, Davis, Dionne, Reid, Caitlin M., Park, Deric M., Gilbert, Mark R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996496/ https://www.ncbi.nlm.nih.gov/pubmed/29891009 http://dx.doi.org/10.1186/s40425-018-0371-5 |
Ejemplares similares
-
Reversing Epigenetic Gene Silencing to Overcome Immune Evasion in CNS Malignancies
por: Ratnam, Nivedita M., et al.
Publicado: (2021) -
Cardiac glycosides suppress the maintenance of stemness and malignancy via inhibiting HIF-1α in human glioma stem cells
por: Lee, Dae-Hee, et al.
Publicado: (2017) -
Cancer immunotherapy by immunosuppression
por: Prehn, Richmond T, et al.
Publicado: (2010) -
Role of the immunosuppressive microenvironment in immunotherapy
por: Tormoen, Garth W., et al.
Publicado: (2018) -
Tumor-Derived Exosomes in Immunosuppression and Immunotherapy
por: Olejarz, Wioletta, et al.
Publicado: (2020)